Meckler Jeffrey A Insider Trades

Insider Trading History

Track insider trading activity for Meckler Jeffrey A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $5.12M 91,500 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$676k 16,000 shares
$42.26
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
May 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$359k 8,000 shares
$44.91
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $5.34M 95,500 shares
Last Trade
May 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$359k 8,000 shares
$44.91
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $4.9M 87,500 shares
Last Trade
May 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$360k 8,000 shares
$45.00
$55.95
Indaptus Therapeutics
Indaptus Therapeutics INDP
Co-chief Executive Officer
Holding Value $45k 12,136 shares
Last Trade
Feb 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.2k 16,688 shares
$1.75
$3.71
Indaptus Therapeutics
Indaptus Therapeutics INDP
Co-chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$29.7k 16,688 shares
$1.78
$3.71
Indaptus Therapeutics
Indaptus Therapeutics INDP
10% owner, Co-chief Executive Officer
Holding Value $853k 229,929 shares
Last Trade
Dec 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$440k 216,617 shares
$2.03
$3.71
Indaptus Therapeutics
Indaptus Therapeutics INDP
Chief Executive Officer
Holding Value $61.9k 16,688 shares
Last Trade
Jul 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 18,204 shares
$9.92
$3.71
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $4.9M 87,500 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 19,500 shares
$21.15
$55.95
Indaptus Therapeutics
Indaptus Therapeutics INDP
CEO And Director
Holding Value $753k 202,859 shares
Last Trade
Nov 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 42,553 shares
$28.84
$3.71
Indaptus Therapeutics
Indaptus Therapeutics INDP
CEO And Director
Holding Value $278k 75,000 shares
Last Trade
Oct 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.33M 75,000 shares
$31.08
$3.71
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $6.77M 121,000 shares
Last Trade
Sep 30, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 80,000 shares
$13.99
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $4.53M 81,000 shares
Last Trade
Sep 30, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$562k 40,000 shares
$14.06
$55.95
Indaptus Therapeutics
Indaptus Therapeutics INDP
CEO And Director
Holding Value $595k 160,306 shares
Last Trade
Aug 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 84,932 shares
$48.44
$3.71
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $4.53M 81,000 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 19,500 shares
$6.82
$55.95
Indaptus Therapeutics
Indaptus Therapeutics INDP
CEO And Director
Holding Value $371k 100,000 shares
Last Trade
Jan 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.87M 100,000 shares
$48.72
$3.71
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $4.17M 74,500 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 13,500 shares
$17.11
$55.95
Indaptus Therapeutics
Indaptus Therapeutics INDP
CEO And Director
Holding Value $371k 100,000 shares
Last Trade
Jan 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.51M 100,000 shares
$45.08
$3.71
Indaptus Therapeutics
Indaptus Therapeutics INDP
CEO And Director
Holding Value $280k 75,374 shares
Last Trade
Nov 21, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$487k 9,600 shares
$50.68
$3.71
Indaptus Therapeutics
Indaptus Therapeutics INDP
CEO And Director
Holding Value $244k 65,774 shares
Last Trade
Nov 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.3k 400 shares
$50.68
$3.71

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up